EichorEICHOR
Location: Carlton Synced from ClinicalTrials.gov · August 10, 2026

Clinical studies recruiting near Carlton

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Phase 2 · Skin Health Institute Inc. · Takeda · NCT07244263A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · NeuroCentrix · Bristol-Myers Squibb · NCT06976216A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Trea
Phase 2 · NeuroCentrix · atai Therapeutics, Inc. · NCT06524830Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder
Phase 2 · NeuroCentrix · HB BioTech, LLC · NCT07499440A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressi
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07196501A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participan
Phase 1 · Skin Health Institute · Zai Lab (Shanghai) Co., Ltd. · NCT07235384A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participant
Phase 3 · Skin Health Institute Inc /ID# 254416 · AbbVie · NCT05889182Dose-Response Effects of Mindfulness Meditation
NA · Contemplative Studies Centre, The University of Melbourne · University of Melbourne · NCT06378450Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Phase 3 · Skin Health Institute Inc. · Bristol-Myers Squibb · NCT07116967A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Sever
Phase 3 · Skin Health Institute Inc /ID# 258570 · AbbVie · NCT06012240Silexan in the Treatment Of Posttraumatic Stress Disorder Trial
Phase 3 · University of Melbourne · Deakin University · NCT06412757REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
Phase 3 · Zenko Clinical Pty Ltd (Virtual Study Site) · Senseye, Inc. · NCT07280065Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Phase 1/Phase 2 · Investigational Site Number : 0360007 · Sanofi Pasteur, a Sanofi Company · NCT06316297A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Phase 3 · NeuroCentrix · Eli Lilly and Company · NCT07412756A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis
Phase 2 · Zai Lab Site 5014 · Zai Lab (Hong Kong), Ltd. · NCT06380907
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.